{
    "abstract": "Background: Typhoid fever remains an important public health problem in developing countries and is endemic in many parts of Asia and Africa where the incidence of disease typically peaks in school-aged children. Age restrictions and other limitations of existing oral live-attenuated typhoid and parenteral Vi polysaccharide vaccines have triggered the development of Vi conjugate vaccines with improved immunological properties, use in younger age range, and longer durability of protection. We present the safety, reactogenicity, and immunogenicity data from a Phase II study after a single dose of Vi polysaccharide conjugated to diphtheria toxoid (Vi-DT) conducted in 6\u201323-month old Filipino children. Methods: This is a randomized, observer-blinded Phase II study to assess the immunogenicity, safety and reactogenicity of Vi-DT compared to placebo, conducted in Muntinlupa City, The Philippines. Participants aged 6\u201323 months were enrolled and randomized to Vi-DT (25 \u00b5g) or placebo (0.9% sodium chloride) and evaluated for immunogenicity and overall safety 28 days post vaccination. Results: A total of 285 participants were enrolled and age-stratified: 6 to < 9 months, 9\u201312 months, and 13\u201323 months. Seventy-six (76) participants received Vi-DT and 19 received placebo per each strata. All participants seroconverted after a single dose of Vi-DT versus 7% of placebo recipients. Anti-Vi IgG GMT was 444.38 [95% CI (400.28; 493.34)] after a single dose of Vi-DT; there was no change in GMT after placebo administration, 0.41 [95% CI (0.33; 0.51), p < 0.0001]. A similar pattern of immunogenicity was reported across all age strata. The vaccine reported to be safe and well tolerated. Conclusions: Vi-DT vaccine was immunogenic, safe, and well tolerated in children aged 6\u201323 months. ClinicalTrials.gov registration number: NCT03527355.",
    "author_highlights": [
        {
            "endOffset": 11821,
            "sentence": "Vi-DT is safe and well tolerated in infants and toddlers aged 6\u201323 months.",
            "startOffset": 11747
        },
        {
            "endOffset": 11900,
            "sentence": "Vi-DT showed >1000-fold higher Geometric Mean Titer (GMT) compared to Placebo.",
            "startOffset": 11822
        },
        {
            "endOffset": 11963,
            "sentence": "100% seroconversion reported in Vi-DT group in all age strata.",
            "startOffset": 11901
        }
    ],
    "bib_entries": {
        "b0005": {
            "authors": [
                {
                    "first": "Jacob",
                    "initial": "J.",
                    "last": "John"
                },
                {
                    "first": "Carola J.C.",
                    "initial": "C.J.C.",
                    "last": "Van Aart"
                },
                {
                    "first": "Nicholas C.",
                    "initial": "N.C.",
                    "last": "Grassly"
                }
            ],
            "doi": "10.1371/journal.pntd.0004616",
            "issn": "19352727",
            "pmid": "27082958",
            "pub_year": 2016,
            "title": "The Burden of Typhoid and Paratyphoid in India: Systematic Review and Meta-analysis",
            "volume": "10"
        },
        "b0010": {
            "authors": [
                {
                    "first": "Jeffrey D.",
                    "initial": "J.D.",
                    "last": "Stanaway"
                },
                {
                    "first": "Robert C.",
                    "initial": "R.C.",
                    "last": "Reiner"
                },
                {
                    "first": "Brigette F.",
                    "initial": "B.F.",
                    "last": "Blacker"
                },
                {
                    "first": "Ellen M.",
                    "initial": "E.M.",
                    "last": "Goldberg"
                },
                {
                    "first": "Ibrahim A.",
                    "initial": "I.A.",
                    "last": "Khalil"
                },
                {
                    "first": "Christopher E.",
                    "initial": "C.E.",
                    "last": "Troeger"
                },
                {
                    "first": "Jason R.",
                    "initial": "J.R.",
                    "last": "Andrews"
                },
                {
                    "first": "Zulfiqar A.",
                    "initial": "Z.A.",
                    "last": "Bhutta"
                },
                {
                    "first": "John A.",
                    "initial": "J.A.",
                    "last": "Crump"
                },
                {
                    "first": "Justin",
                    "initial": "J.",
                    "last": "Im"
                },
                {
                    "first": "Florian",
                    "initial": "F.",
                    "last": "Marks"
                },
                {
                    "first": "Eric",
                    "initial": "E.",
                    "last": "Mintz"
                },
                {
                    "first": "Se Eun",
                    "initial": "S.E.",
                    "last": "Park"
                },
                {
                    "first": "Anita K.M.",
                    "initial": "A.K.M.",
                    "last": "Zaidi"
                },
                {
                    "first": "Zegeye",
                    "initial": "Z.",
                    "last": "Abebe"
                },
                {
                    "first": "Ayenew Negesse",
                    "initial": "A.N.",
                    "last": "Abejie"
                },
                {
                    "first": "Isaac Akinkunmi",
                    "initial": "I.A.",
                    "last": "Adedeji"
                },
                {
                    "first": "Beriwan Abdulqadir",
                    "initial": "B.A.",
                    "last": "Ali"
                },
                {
                    "first": "Azmeraw T.",
                    "initial": "A.T.",
                    "last": "Amare"
                },
                {
                    "first": "Hagos Tasew",
                    "initial": "H.T.",
                    "last": "Atalay"
                },
                {
                    "first": "Euripide F.G.A.",
                    "initial": "E.F.G.A.",
                    "last": "Avokpaho"
                },
                {
                    "first": "Umar",
                    "initial": "U.",
                    "last": "Bacha"
                },
                {
                    "first": "Aleksandra",
                    "initial": "A.",
                    "last": "Barac"
                },
                {
                    "first": "Neeraj",
                    "initial": "N.",
                    "last": "Bedi"
                },
                {
                    "first": "Adugnaw",
                    "initial": "A.",
                    "last": "Berhane"
                },
                {
                    "first": "Annie J.",
                    "initial": "A.J.",
                    "last": "Browne"
                },
                {
                    "first": "Jesus L.",
                    "initial": "J.L.",
                    "last": "Chirinos"
                },
                {
                    "first": "Abdulaal",
                    "initial": "A.",
                    "last": "Chitheer"
                },
                {
                    "first": "Christiane",
                    "initial": "C.",
                    "last": "Dolecek"
                },
                {
                    "first": "Maysaa",
                    "initial": "M.",
                    "last": "El Sayed Zaki"
                },
                {
                    "first": "Babak",
                    "initial": "B.",
                    "last": "Eshrati"
                },
                {
                    "first": "Kyle J.",
                    "initial": "K.J.",
                    "last": "Foreman"
                },
                {
                    "first": "Abdella",
                    "initial": "A.",
                    "last": "Gemechu"
                },
                {
                    "first": "Rahul",
                    "initial": "R.",
                    "last": "Gupta"
                },
                {
                    "first": "Gessessew Bugssa",
                    "initial": "G.B.",
                    "last": "Hailu"
                },
                {
                    "first": "Andualem",
                    "initial": "A.",
                    "last": "Henok"
                },
                {
                    "first": "Desalegn Tsegaw",
                    "initial": "D.T.",
                    "last": "Hibstu"
                },
                {
                    "first": "Chi Linh",
                    "initial": "C.L.",
                    "last": "Hoang"
                },
                {
                    "first": "Olayinka Stephen",
                    "initial": "O.S.",
                    "last": "Ilesanmi"
                },
                {
                    "first": "Veena J.",
                    "initial": "V.J.",
                    "last": "Iyer"
                },
                {
                    "first": "Amaha",
                    "initial": "A.",
                    "last": "Kahsay"
                },
                {
                    "first": "Amir",
                    "initial": "A.",
                    "last": "Kasaeian"
                },
                {
                    "first": "Tesfaye Dessale",
                    "initial": "T.D.",
                    "last": "Kassa"
                },
                {
                    "first": "Ejaz Ahmad",
                    "initial": "E.A.",
                    "last": "Khan"
                },
                {
                    "first": "Young Ho",
                    "initial": "Y.H.",
                    "last": "Khang"
                },
                {
                    "first": "Hassan",
                    "initial": "H.",
                    "last": "Magdy Abd El Razek"
                },
                {
                    "first": "Mulugeta",
                    "initial": "M.",
                    "last": "Melku"
                },
                {
                    "first": "Desalegn Tadese",
                    "initial": "D.T.",
                    "last": "Mengistu"
                },
                {
                    "first": "Karzan Abdulmuhsin",
                    "initial": "K.A.",
                    "last": "Mohammad"
                },
                {
                    "first": "Shafiu",
                    "initial": "S.",
                    "last": "Mohammed"
                },
                {
                    "first": "Ali H.",
                    "initial": "A.H.",
                    "last": "Mokdad"
                },
                {
                    "first": "Jean B.",
                    "initial": "J.B.",
                    "last": "Nachega"
                },
                {
                    "first": "Aliya",
                    "initial": "A.",
                    "last": "Naheed"
                },
                {
                    "first": "Cuong Tat",
                    "initial": "C.T.",
                    "last": "Nguyen"
                },
                {
                    "first": "Huong Lan Thi",
                    "initial": "H.L.T.",
                    "last": "Nguyen"
                },
                {
                    "first": "Long Hoang",
                    "initial": "L.H.",
                    "last": "Nguyen"
                },
                {
                    "first": "Nam Ba",
                    "initial": "N.B.",
                    "last": "Nguyen"
                },
                {
                    "first": "Trang Huyen",
                    "initial": "T.H.",
                    "last": "Nguyen"
                },
                {
                    "first": "Yirga Legesse",
                    "initial": "Y.L.",
                    "last": "Nirayo"
                },
                {
                    "first": "Tikki",
                    "initial": "T.",
                    "last": "Pangestu"
                },
                {
                    "first": "George C.",
                    "initial": "G.C.",
                    "last": "Patton"
                },
                {
                    "first": "Mostafa",
                    "initial": "M.",
                    "last": "Qorbani"
                },
                {
                    "first": "Rajesh Kumar",
                    "initial": "R.K.",
                    "last": "Rai"
                },
                {
                    "first": "Saleem M.",
                    "initial": "S.M.",
                    "last": "Rana"
                },
                {
                    "first": "Chhabi Lal",
                    "initial": "C.L.",
                    "last": "Ranabhat"
                },
                {
                    "first": "Kedir Teji",
                    "initial": "K.T.",
                    "last": "Roba"
                },
                {
                    "first": "Nicholas L.S.",
                    "initial": "N.L.S.",
                    "last": "Roberts"
                },
                {
                    "first": "Salvatore",
                    "initial": "S.",
                    "last": "Rubino"
                },
                {
                    "first": "Saeid",
                    "initial": "S.",
                    "last": "Safiri"
                },
                {
                    "first": "Benn",
                    "initial": "B.",
                    "last": "Sartorius"
                },
                {
                    "first": "Monika",
                    "initial": "M.",
                    "last": "Sawhney"
                },
                {
                    "first": "Mekonnen Sisay",
                    "initial": "M.S.",
                    "last": "Shiferaw"
                },
                {
                    "first": "David L.",
                    "initial": "D.L.",
                    "last": "Smith"
                },
                {
                    "first": "Bryan L.",
                    "initial": "B.L.",
                    "last": "Sykes"
                },
                {
                    "first": "Bach Xuan",
                    "initial": "B.X.",
                    "last": "Tran"
                },
                {
                    "first": "Tung Thanh",
                    "initial": "T.T.",
                    "last": "Tran"
                },
                {
                    "first": "Kingsley Nnanna",
                    "initial": "K.N.",
                    "last": "Ukwaja"
                },
                {
                    "first": "Giang Thu",
                    "initial": "G.T.",
                    "last": "Vu"
                },
                {
                    "first": "Linh Gia",
                    "initial": "L.G.",
                    "last": "Vu"
                },
                {
                    "first": "Fitsum",
                    "initial": "F.",
                    "last": "Weldegebreal"
                },
                {
                    "first": "Melaku Kindie",
                    "initial": "M.K.",
                    "last": "Yenit"
                },
                {
                    "first": "Christopher J.L.",
                    "initial": "C.J.L.",
                    "last": "Murray"
                },
                {
                    "first": "Simon I.",
                    "initial": "S.I.",
                    "last": "Hay"
                },
                {
                    "first": null,
                    "initial": null,
                    "last": null
                }
            ],
            "doi": "10.1016/S1473-3099(18)30685-6",
            "firstpage": "369",
            "issn": "14733099",
            "lastpage": "381",
            "pmid": "30792131",
            "pub_year": 2019,
            "title": "The global burden of typhoid and paratyphoid fevers: a systematic analysis for the Global Burden of Disease Study 2017",
            "volume": "19"
        },
        "b0015": {
            "authors": [
                {
                    "first": "P.",
                    "initial": "P.",
                    "last": "Erma Abucejo"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Rosario Capeding"
                },
                {
                    "first": "Socorro P.",
                    "initial": "S.P.",
                    "last": "Lupisan"
                },
                {
                    "first": "Juanita",
                    "initial": "J.",
                    "last": "Arcay"
                },
                {
                    "first": "Lydia T.",
                    "initial": "L.T.",
                    "last": "Sombrero"
                },
                {
                    "first": "Petri",
                    "initial": "P.",
                    "last": "Ruutu"
                },
                {
                    "first": "Elja",
                    "initial": "E.",
                    "last": "Herva"
                }
            ],
            "firstpage": "531",
            "issn": "01251562",
            "lastpage": "536",
            "pmid": "11944712",
            "pub_year": 2001,
            "title": "Blood culture confirmed typhoid fever in a provincial hospital in the Philippines",
            "volume": "32"
        },
        "b0020": null,
        "b0025": null,
        "b0030": {
            "authors": [
                {
                    "first": "John A.",
                    "initial": "J.A.",
                    "last": "Crump"
                },
                {
                    "first": "Stephen P.",
                    "initial": "S.P.",
                    "last": "Luby"
                },
                {
                    "first": "Eric D.",
                    "initial": "E.D.",
                    "last": "Mintz"
                }
            ],
            "firstpage": "346",
            "issn": "00429686",
            "lastpage": "353",
            "pmid": "15298225",
            "pub_year": 2004,
            "title": "The global burden of typhoid fever",
            "volume": "82"
        },
        "b0035": {
            "authors": [
                {
                    "first": "John A.",
                    "initial": "J.A.",
                    "last": "Crump"
                },
                {
                    "first": "Eric D.",
                    "initial": "E.D.",
                    "last": "Mintz"
                }
            ],
            "doi": "10.1086/649541",
            "firstpage": "241",
            "issn": "10584838",
            "lastpage": "246",
            "pmid": "20014951",
            "pub_year": 2010,
            "title": "Global trends in typhoid and paratyphoid fever",
            "volume": "50"
        },
        "b0040": null,
        "b0045": {
            "authors": [
                {
                    "first": "Geoffrey C.",
                    "initial": "G.C.",
                    "last": "Buckle"
                },
                {
                    "first": "Christa L.Fischer",
                    "initial": "C.L.F.",
                    "last": "Walker"
                },
                {
                    "first": "Robert E.",
                    "initial": "R.E.",
                    "last": "Black"
                }
            ],
            "doi": "10.7189/jogh.02.010401",
            "issn": "20472978",
            "pub_year": 2012,
            "title": "Typhoid fever and paratyphoid fever: Systematic review to estimate global morbidity and mortality for 2010",
            "volume": "2"
        },
        "b0050": {
            "authors": [
                {
                    "first": "Zulfiqar A.",
                    "initial": "Z.A.",
                    "last": "Bhutta"
                },
                {
                    "first": "Maria Rosario",
                    "initial": "M.R.",
                    "last": "Capeding"
                },
                {
                    "first": "Ashish",
                    "initial": "A.",
                    "last": "Bavdekar"
                },
                {
                    "first": "Elisa",
                    "initial": "E.",
                    "last": "Marchetti"
                },
                {
                    "first": "Shabina",
                    "initial": "S.",
                    "last": "Ariff"
                },
                {
                    "first": "Sajid B.",
                    "initial": "S.B.",
                    "last": "Soofi"
                },
                {
                    "first": "Alessandra",
                    "initial": "A.",
                    "last": "Anemona"
                },
                {
                    "first": "Muhammad A.",
                    "initial": "M.A.",
                    "last": "Habib"
                },
                {
                    "first": "Edison",
                    "initial": "E.",
                    "last": "Alberto"
                },
                {
                    "first": "Sanjay",
                    "initial": "S.",
                    "last": "Juvekar"
                },
                {
                    "first": "Rana M.Qasim",
                    "initial": "R.M.Q.",
                    "last": "Khan"
                },
                {
                    "first": "Rachid",
                    "initial": "R.",
                    "last": "Marhaba"
                },
                {
                    "first": "Noshad",
                    "initial": "N.",
                    "last": "Ali"
                },
                {
                    "first": "Nelia",
                    "initial": "N.",
                    "last": "Malubay"
                },
                {
                    "first": "Anand",
                    "initial": "A.",
                    "last": "Kawade"
                },
                {
                    "first": "Allan",
                    "initial": "A.",
                    "last": "Saul"
                },
                {
                    "first": "Laura B.",
                    "initial": "L.B.",
                    "last": "Martin"
                },
                {
                    "first": "Audino",
                    "initial": "A.",
                    "last": "Podda"
                }
            ],
            "doi": "10.1016/S1473-3099(13)70241-X",
            "firstpage": "119",
            "issn": "14733099",
            "lastpage": "129",
            "pmid": "24290843",
            "pub_year": 2014,
            "title": "Immunogenicity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: Results from two randomised, observer-blind, age de-escalation, phase 2 trials",
            "volume": "14"
        },
        "b0055": {
            "authors": [
                {
                    "first": "Aatekah",
                    "initial": "A.",
                    "last": "Owais"
                },
                {
                    "first": "Shazia",
                    "initial": "S.",
                    "last": "Sultana"
                },
                {
                    "first": "Umber",
                    "initial": "U.",
                    "last": "Zaman"
                },
                {
                    "first": "Arjumand",
                    "initial": "A.",
                    "last": "Rizvi"
                },
                {
                    "first": "Anita K.M.",
                    "initial": "A.K.M.",
                    "last": "Zaidi"
                }
            ],
            "doi": "10.1097/INF.0b013e3181e39f8b",
            "firstpage": "1035",
            "issn": "08913668",
            "lastpage": "1039",
            "pub_year": 2010,
            "title": "Incidence of typhoid bacteremia in infants and young children in Southern Coastal Pakistan",
            "volume": "29"
        },
        "b0060": {
            "authors": [
                {
                    "first": "Feng Ying C.",
                    "initial": "F.Y.C.",
                    "last": "Lin"
                },
                {
                    "first": "Vo Anh",
                    "initial": "V.A.",
                    "last": "Ho"
                },
                {
                    "first": "Ha Ba",
                    "initial": "H.B.",
                    "last": "Khiem"
                },
                {
                    "first": "Dang Duc",
                    "initial": "D.D.",
                    "last": "Trach"
                },
                {
                    "first": "Phan Van",
                    "initial": "P.V.",
                    "last": "Bay"
                },
                {
                    "first": "Tran Cong",
                    "initial": "T.C.",
                    "last": "Thanh"
                },
                {
                    "first": "Zuzana",
                    "initial": "Z.",
                    "last": "Kossaczka"
                },
                {
                    "first": "Dolores A.",
                    "initial": "D.A.",
                    "last": "Bryla"
                },
                {
                    "first": "Joseph",
                    "initial": "J.",
                    "last": "Shiloach"
                },
                {
                    "first": "John B.",
                    "initial": "J.B.",
                    "last": "Robbins"
                },
                {
                    "first": "Rachel",
                    "initial": "R.",
                    "last": "Schneerson"
                },
                {
                    "first": "Shousun C.",
                    "initial": "S.C.",
                    "last": "Szu"
                }
            ],
            "doi": "10.1056/NEJM200104263441701",
            "firstpage": "1263",
            "issn": "00284793",
            "lastpage": "1269",
            "pmid": "11320385",
            "pub_year": 2001,
            "title": "The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children",
            "volume": "344"
        },
        "b0065": {
            "authors": [
                {
                    "first": "R. Leon",
                    "initial": "R.L.",
                    "last": "Ochiai"
                },
                {
                    "first": "Camilo J.",
                    "initial": "C.J.",
                    "last": "Acosta"
                },
                {
                    "first": "M. Carolina",
                    "initial": "M.C.",
                    "last": "Danovaro-Holliday"
                },
                {
                    "first": "Dong",
                    "initial": "D.",
                    "last": "Baiqing"
                },
                {
                    "first": "Sujit K.",
                    "initial": "S.K.",
                    "last": "Bhattacharya"
                },
                {
                    "first": "Magdarina D.",
                    "initial": "M.D.",
                    "last": "Agtini"
                },
                {
                    "first": "Zulfiqar A.",
                    "initial": "Z.A.",
                    "last": "Bhutta"
                },
                {
                    "first": "Do Gia",
                    "initial": "D.G.",
                    "last": "Canh"
                },
                {
                    "first": "Mohammad",
                    "initial": "M.",
                    "last": "Ali"
                },
                {
                    "first": "Seonghye",
                    "initial": "S.",
                    "last": "Shin"
                },
                {
                    "first": "John",
                    "initial": "J.",
                    "last": "Wain"
                },
                {
                    "first": "Anne Laure",
                    "initial": "A.L.",
                    "last": "Page"
                },
                {
                    "first": "M. John",
                    "initial": "M.J.",
                    "last": "Albert"
                },
                {
                    "first": "Jeremy",
                    "initial": "J.",
                    "last": "Farrar"
                },
                {
                    "first": "Remon",
                    "initial": "R.",
                    "last": "Abu-Elyazeed"
                },
                {
                    "first": "Tikki",
                    "initial": "T.",
                    "last": "Pang"
                },
                {
                    "first": "Claudia M.",
                    "initial": "C.M.",
                    "last": "Galindo"
                },
                {
                    "first": "Lorenz",
                    "initial": "L.",
                    "last": "Von Seidlein"
                },
                {
                    "first": "John D.",
                    "initial": "J.D.",
                    "last": "Clemens"
                },
                {
                    "first": "Yang",
                    "initial": "Y.",
                    "last": "Jin"
                },
                {
                    "first": "Liang",
                    "initial": "L.",
                    "last": "Dabin"
                },
                {
                    "first": "Wang",
                    "initial": "W.",
                    "last": "Mingliu"
                },
                {
                    "first": "Yang",
                    "initial": "Y.",
                    "last": "Honghui"
                },
                {
                    "first": "Dipika",
                    "initial": "D.",
                    "last": "Sur"
                },
                {
                    "first": "Byomkesh",
                    "initial": "B.",
                    "last": "Manna"
                },
                {
                    "first": "Shanta",
                    "initial": "S.",
                    "last": "Dutta"
                },
                {
                    "first": "S. Qamaruddin",
                    "initial": "S.Q.",
                    "last": "Nizami"
                },
                {
                    "first": "Mohammad Imran",
                    "initial": "M.I.",
                    "last": "Khan"
                },
                {
                    "first": "Rumina",
                    "initial": "R.",
                    "last": "Hassan"
                },
                {
                    "first": "Duc Anh",
                    "initial": "D.A.",
                    "last": "Dang"
                },
                {
                    "first": "Din Thiem",
                    "initial": "D.T.",
                    "last": "Vu"
                },
                {
                    "first": "S. H.",
                    "initial": "S.H.",
                    "last": "Nguyen"
                },
                {
                    "first": "P. T.",
                    "initial": "P.T.",
                    "last": "Hoang"
                },
                {
                    "first": "Cyrus",
                    "initial": "C.",
                    "last": "Simanjuntak"
                },
                {
                    "first": "Narain",
                    "initial": "N.",
                    "last": "Punjabi"
                },
                {
                    "first": "Jacqueline L.",
                    "initial": "J.L.",
                    "last": "Deen"
                },
                {
                    "first": "Zhi Yi",
                    "initial": "Z.Y.",
                    "last": "Xu"
                },
                {
                    "first": "Jin Kyung",
                    "initial": "J.K.",
                    "last": "Park"
                },
                {
                    "first": "Luis",
                    "initial": "L.",
                    "last": "Jodar"
                }
            ],
            "doi": "10.2471/BLT.06.039818",
            "firstpage": "260",
            "issn": "00429686",
            "lastpage": "268",
            "pmid": "18438514",
            "pub_year": 2008,
            "title": "A study of typhoid fever in five Asian countries: Disease burden and implications for controls",
            "volume": "86"
        },
        "b0070": {
            "authors": [
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Gaind"
                },
                {
                    "first": "B.",
                    "initial": "B.",
                    "last": "Paglietti"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Murgia"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Dawar"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Uzzau"
                },
                {
                    "first": "P.",
                    "initial": "P.",
                    "last": "Cappuccinelli"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Deb"
                },
                {
                    "first": "P.",
                    "initial": "P.",
                    "last": "Aggarwal"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Rubino"
                }
            ],
            "doi": "10.1093/jac/dkl391",
            "firstpage": "1139",
            "issn": "03057453",
            "lastpage": "1144",
            "pmid": "17071955",
            "pub_year": 2006,
            "title": "Molecular characterization of ciprofloxacin-resistant Salmonella enterica serovar Typhi and Paratyphi A causing enteric fever in India",
            "volume": "58"
        },
        "b0075": {
            "authors": [
                {
                    "first": "Amit",
                    "initial": "A.",
                    "last": "Arjyal"
                },
                {
                    "first": "Buddha",
                    "initial": "B.",
                    "last": "Basnyat"
                },
                {
                    "first": "Ho Thi",
                    "initial": "H.T.",
                    "last": "Nhan"
                },
                {
                    "first": "Samir",
                    "initial": "S.",
                    "last": "Koirala"
                },
                {
                    "first": "Abhishek",
                    "initial": "A.",
                    "last": "Giri"
                },
                {
                    "first": "Niva",
                    "initial": "N.",
                    "last": "Joshi"
                },
                {
                    "first": "Mila",
                    "initial": "M.",
                    "last": "Shakya"
                },
                {
                    "first": "Kamal Raj",
                    "initial": "K.R.",
                    "last": "Pathak"
                },
                {
                    "first": "Saruna Pathak",
                    "initial": "S.P.",
                    "last": "Mahat"
                },
                {
                    "first": "Shanti Pradhan",
                    "initial": "S.P.",
                    "last": "Prajapati"
                },
                {
                    "first": "Nabin",
                    "initial": "N.",
                    "last": "Adhikari"
                },
                {
                    "first": "Rajkumar",
                    "initial": "R.",
                    "last": "Thapa"
                },
                {
                    "first": "Laura",
                    "initial": "L.",
                    "last": "Merson"
                },
                {
                    "first": "Damodar",
                    "initial": "D.",
                    "last": "Gajurel"
                },
                {
                    "first": "Kamal",
                    "initial": "K.",
                    "last": "Lamsal"
                },
                {
                    "first": "Dinesh",
                    "initial": "D.",
                    "last": "Lamsal"
                },
                {
                    "first": "Bharat Kumar",
                    "initial": "B.K.",
                    "last": "Yadav"
                },
                {
                    "first": "Ganesh",
                    "initial": "G.",
                    "last": "Shah"
                },
                {
                    "first": "Poojan",
                    "initial": "P.",
                    "last": "Shrestha"
                },
                {
                    "first": "Sabina",
                    "initial": "S.",
                    "last": "Dongol"
                },
                {
                    "first": "Abhilasha",
                    "initial": "A.",
                    "last": "Karkey"
                },
                {
                    "first": "Corinne N.",
                    "initial": "C.N.",
                    "last": "Thompson"
                },
                {
                    "first": "Nga Tran Vu",
                    "initial": "N.T.V.",
                    "last": "Thieu"
                },
                {
                    "first": "Duy Pham",
                    "initial": "D.P.",
                    "last": "Thanh"
                },
                {
                    "first": "Stephen",
                    "initial": "S.",
                    "last": "Baker"
                },
                {
                    "first": "Guy E.",
                    "initial": "G.E.",
                    "last": "Thwaites"
                },
                {
                    "first": "Marcel",
                    "initial": "M.",
                    "last": "Wolbers"
                },
                {
                    "first": "Christiane",
                    "initial": "C.",
                    "last": "Dolecek"
                }
            ],
            "doi": "10.1016/S1473-3099(15)00530-7",
            "firstpage": "535",
            "issn": "14733099",
            "lastpage": "545",
            "pmid": "26809813",
            "pub_year": 2016,
            "title": "Gatifloxacin versus ceftriaxone for uncomplicated enteric fever in Nepal: An open-label, two-centre, randomised controlled trial",
            "volume": "16"
        },
        "b0080": {
            "authors": [
                {
                    "first": "Karen H.",
                    "initial": "K.H.",
                    "last": "Keddy"
                },
                {
                    "first": "Anthony M.",
                    "initial": "A.M.",
                    "last": "Smith"
                },
                {
                    "first": "Arvinda",
                    "initial": "A.",
                    "last": "Sooka"
                },
                {
                    "first": "Husna",
                    "initial": "H.",
                    "last": "Ismail"
                },
                {
                    "first": "Stephen",
                    "initial": "S.",
                    "last": "Oliver"
                }
            ],
            "doi": "10.3201/eid1605.091917",
            "firstpage": "879",
            "issn": "10806040",
            "lastpage": "880",
            "pmid": "20409393",
            "pub_year": 2010,
            "title": "Fluoroquinolone- resistant typhoid, South Africa",
            "volume": "16"
        },
        "b0085": {
            "authors": [
                {
                    "first": "Octavie",
                    "initial": "O.",
                    "last": "Lunguya"
                },
                {
                    "first": "Veerle",
                    "initial": "V.",
                    "last": "Lejon"
                },
                {
                    "first": "Marie France",
                    "initial": "M.F.",
                    "last": "Phoba"
                },
                {
                    "first": "Sophie",
                    "initial": "S.",
                    "last": "Bertrand"
                },
                {
                    "first": "Raymond",
                    "initial": "R.",
                    "last": "Vanhoof"
                },
                {
                    "first": "Jan",
                    "initial": "J.",
                    "last": "Verhaegen"
                },
                {
                    "first": "Anthony Marius",
                    "initial": "A.M.",
                    "last": "Smith"
                },
                {
                    "first": "Karen Helena",
                    "initial": "K.H.",
                    "last": "Keddy"
                },
                {
                    "first": "Jean Jacques",
                    "initial": "J.J.",
                    "last": "Muyembe-Tamfum"
                },
                {
                    "first": "Jan",
                    "initial": "J.",
                    "last": "Jacobs"
                }
            ],
            "doi": "10.1371/journal.pntd.0001921",
            "issn": "19352735",
            "pmid": "23166855",
            "pub_year": 2012,
            "title": "Salmonella typhi in the democratic republic of the congo: fluoroquinolone decreased susceptibility on the rise.",
            "volume": "6"
        },
        "b0090": {
            "authors": [
                {
                    "first": "John A.",
                    "initial": "J.A.",
                    "last": "Crump"
                },
                {
                    "first": "Maria",
                    "initial": "M.",
                    "last": "Sj\u00f6lund-Karlsson"
                },
                {
                    "first": "Melita A.",
                    "initial": "M.A.",
                    "last": "Gordon"
                },
                {
                    "first": "Christopher M.",
                    "initial": "C.M.",
                    "last": "Parry"
                }
            ],
            "doi": "10.1128/CMR.00002-15",
            "firstpage": "901",
            "issn": "08938512",
            "lastpage": "937",
            "pmid": "26180063",
            "pub_year": 2015,
            "title": "Epidemiology, clinical presentation, laboratory diagnosis, antimicrobial resistance, and antimicrobial management of invasive Salmonella infections",
            "volume": "28"
        },
        "b0095": {
            "authors": [
                {
                    "first": "John",
                    "initial": "J.",
                    "last": "Wain"
                },
                {
                    "first": "Rene S.",
                    "initial": "R.S.",
                    "last": "Hendriksen"
                },
                {
                    "first": "Matthew L.",
                    "initial": "M.L.",
                    "last": "Mikoleit"
                },
                {
                    "first": "Karen H.",
                    "initial": "K.H.",
                    "last": "Keddy"
                },
                {
                    "first": "R. Leon",
                    "initial": "R.L.",
                    "last": "Ochiai"
                }
            ],
            "doi": "10.1016/S0140-6736(13)62708-7",
            "firstpage": "1136",
            "issn": "01406736",
            "lastpage": "1145",
            "pmid": "25458731",
            "pub_year": 2015,
            "title": "Typhoid fever",
            "volume": "385"
        },
        "b0100": null,
        "b0105": null,
        "b0110": {
            "authors": [
                {
                    "first": "Marina",
                    "initial": "M.",
                    "last": "Antill\u00f3n"
                },
                {
                    "first": "Joke",
                    "initial": "J.",
                    "last": "Bilcke"
                },
                {
                    "first": "A. David",
                    "initial": "A.D.",
                    "last": "Paltiel"
                },
                {
                    "first": "Virginia E.",
                    "initial": "V.E.",
                    "last": "Pitzer"
                }
            ],
            "doi": "10.1016/j.vaccine.2017.05.001",
            "firstpage": "3506",
            "issn": "0264410X",
            "lastpage": "3514",
            "pmid": "28527687",
            "pub_year": 2017,
            "title": "Cost-effectiveness analysis of typhoid conjugate vaccines in five endemic low- and middle-income settings",
            "volume": "35"
        },
        "b0115": {
            "authors": [
                {
                    "first": "Maria Rosario",
                    "initial": "M.R.",
                    "last": "Capeding"
                },
                {
                    "first": "Samuel",
                    "initial": "S.",
                    "last": "Teshome"
                },
                {
                    "first": "Tarun",
                    "initial": "T.",
                    "last": "Saluja"
                },
                {
                    "first": "Khalid Ali",
                    "initial": "K.A.",
                    "last": "Syed"
                },
                {
                    "first": "Deok Ryun",
                    "initial": "D.R.",
                    "last": "Kim"
                },
                {
                    "first": "Ju Yeon",
                    "initial": "J.Y.",
                    "last": "Park"
                },
                {
                    "first": "Jae Seung",
                    "initial": "J.S.",
                    "last": "Yang"
                },
                {
                    "first": "Yang Hee",
                    "initial": "Y.H.",
                    "last": "Kim"
                },
                {
                    "first": "Jiwook",
                    "initial": "J.",
                    "last": "Park"
                },
                {
                    "first": "Sue Kyoung",
                    "initial": "S.K.",
                    "last": "Jo"
                },
                {
                    "first": "Yun",
                    "initial": "Y.",
                    "last": "Chon"
                },
                {
                    "first": "Sudeep",
                    "initial": "S.",
                    "last": "Kothari"
                },
                {
                    "first": "Seon Young",
                    "initial": "S.Y.",
                    "last": "Yang"
                },
                {
                    "first": "Dong Soo",
                    "initial": "D.S.",
                    "last": "Ham"
                },
                {
                    "first": "Ji Hwa",
                    "initial": "J.H.",
                    "last": "Ryu"
                },
                {
                    "first": "Hee Seong",
                    "initial": "H.S.",
                    "last": "Hwang"
                },
                {
                    "first": "Ju Hwan",
                    "initial": "J.H.",
                    "last": "Mun"
                },
                {
                    "first": "Julia A.",
                    "initial": "J.A.",
                    "last": "Lynch"
                },
                {
                    "first": "Jerome H.",
                    "initial": "J.H.",
                    "last": "Kim"
                },
                {
                    "first": "Hun",
                    "initial": "H.",
                    "last": "Kim"
                },
                {
                    "first": "Jean Louis",
                    "initial": "J.L.",
                    "last": "Excler"
                },
                {
                    "first": "Sushant",
                    "initial": "S.",
                    "last": "Sahastrabuddhe"
                }
            ],
            "doi": "10.1016/j.vaccine.2018.05.038",
            "firstpage": "3794",
            "issn": "0264410X",
            "lastpage": "3801",
            "pmid": "29776750",
            "pub_year": 2018,
            "title": "Safety and immunogenicity of a Vi-DT typhoid conjugate vaccine: Phase I trial in Healthy Filipino adults and children",
            "volume": "36"
        },
        "b0120": {
            "authors": [
                {
                    "first": "Sushant",
                    "initial": "S.",
                    "last": "Sahastrabuddhe"
                },
                {
                    "first": "Tarun",
                    "initial": "T.",
                    "last": "Saluja"
                }
            ],
            "doi": "10.1093/cid/ciy884",
            "firstpage": "S22",
            "issn": "10584838",
            "lastpage": "S26",
            "pmid": "30767002",
            "pub_year": 2019,
            "title": "Overview of the Typhoid Conjugate Vaccine Pipeline: Current Status and Future Plans",
            "volume": "68"
        },
        "b0125": {
            "authors": [
                {
                    "first": "Sjoerd",
                    "initial": "S.",
                    "last": "Rijpkema"
                },
                {
                    "first": "Jason",
                    "initial": "J.",
                    "last": "Hockley"
                },
                {
                    "first": "Alastair",
                    "initial": "A.",
                    "last": "Logan"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Rigsby"
                },
                {
                    "first": "Eleanor",
                    "initial": "E.",
                    "last": "Atkinson"
                },
                {
                    "first": "Celina",
                    "initial": "C.",
                    "last": "Jin"
                },
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Goldblatt"
                },
                {
                    "first": "Haoyu",
                    "initial": "H.",
                    "last": "Liang"
                },
                {
                    "first": "Novilia S.",
                    "initial": "N.S.",
                    "last": "Bachtiar"
                },
                {
                    "first": "Jae Seung",
                    "initial": "J.S.",
                    "last": "Yang"
                },
                {
                    "first": "Akshay",
                    "initial": "A.",
                    "last": "Goel"
                },
                {
                    "first": "Venkatesan",
                    "initial": "V.",
                    "last": "Ramasamy"
                },
                {
                    "first": "Marcela F.",
                    "initial": "M.F.",
                    "last": "Pasetti"
                },
                {
                    "first": "Andrew J.",
                    "initial": "A.J.",
                    "last": "Pollard"
                },
                {
                    "first": null,
                    "initial": null,
                    "last": null
                }
            ],
            "doi": "10.1016/j.biologicals.2018.09.001",
            "firstpage": "29",
            "issn": "10451056",
            "lastpage": "38",
            "pmid": "30201529",
            "pub_year": 2018,
            "title": "Establishment of the first International Standard for human anti-typhoid capsular Vi polysaccharide IgG",
            "volume": "56"
        },
        "b0130": {
            "authors": [
                {
                    "first": "H.",
                    "initial": "H.",
                    "last": "Jakobsen"
                },
                {
                    "first": "I.",
                    "initial": "I.",
                    "last": "Jonsdottir"
                }
            ],
            "doi": "10.1046/j.1365-3083.2003.01292.x",
            "firstpage": "119",
            "issn": "03009475",
            "lastpage": "128",
            "pmid": "12869132",
            "pub_year": 2003,
            "title": "Mucosal vaccination against encapsulated respiratory bacteria - New potentials for conjugate vaccines?",
            "volume": "58"
        },
        "b0135": {
            "authors": [
                {
                    "first": "So Jung",
                    "initial": "S.J.",
                    "last": "An"
                },
                {
                    "first": "Yeon Kyung",
                    "initial": "Y.K.",
                    "last": "Yoon"
                },
                {
                    "first": "Sudeep",
                    "initial": "S.",
                    "last": "Kothari"
                },
                {
                    "first": "Deok Ryun",
                    "initial": "D.R.",
                    "last": "Kim"
                },
                {
                    "first": "Jeong Ah",
                    "initial": "J.A.",
                    "last": "Kim"
                },
                {
                    "first": "Neha",
                    "initial": "N.",
                    "last": "Kothari"
                },
                {
                    "first": "Eugene",
                    "initial": "E.",
                    "last": "Lee"
                },
                {
                    "first": "Tai Hyun",
                    "initial": "T.H.",
                    "last": "Park"
                },
                {
                    "first": "Rodney",
                    "initial": "R.",
                    "last": "Carbis"
                }
            ],
            "doi": "10.1016/j.vaccine.2011.12.046",
            "firstpage": "1023",
            "issn": "0264410X",
            "lastpage": "1028",
            "pmid": "22192846",
            "pub_year": 2012,
            "title": "Immune suppression induced by Vi capsular polysaccharide is overcome by Vi-DT conjugate vaccine",
            "volume": "30"
        },
        "b0140": {
            "authors": [
                {
                    "first": "Pierre",
                    "initial": "P.",
                    "last": "van Damme"
                },
                {
                    "first": "Froukje",
                    "initial": "F.",
                    "last": "Kafeja"
                },
                {
                    "first": "Alessandra",
                    "initial": "A.",
                    "last": "Anemona"
                },
                {
                    "first": "Venere",
                    "initial": "V.",
                    "last": "Basile"
                },
                {
                    "first": "Anne Katrin",
                    "initial": "A.K.",
                    "last": "Hilbert"
                },
                {
                    "first": "Ilse",
                    "initial": "I.",
                    "last": "de Coster"
                },
                {
                    "first": "Simona",
                    "initial": "S.",
                    "last": "Rondini"
                },
                {
                    "first": "Francesca",
                    "initial": "F.",
                    "last": "Micoli"
                },
                {
                    "first": "Rana M.",
                    "initial": "R.M.",
                    "last": "Khan"
                },
                {
                    "first": "Elisa",
                    "initial": "E.",
                    "last": "Marchetti"
                },
                {
                    "first": "Vito",
                    "initial": "V.",
                    "last": "Di Cioccio"
                },
                {
                    "first": "Allan",
                    "initial": "A.",
                    "last": "Saul"
                },
                {
                    "first": "Laura B.",
                    "initial": "L.B.",
                    "last": "Martin"
                },
                {
                    "first": "Audino",
                    "initial": "A.",
                    "last": "Podda"
                }
            ],
            "doi": "10.1371/journal.pone.0025398",
            "issn": "19326203",
            "pmid": "21980445",
            "pub_year": 2011,
            "title": "Safety, immunogenicity and dose ranging of a new VI-CRM 197 conjugate vaccine against typhoid fever: Randomized clinical testing in healthy adults",
            "volume": "6"
        },
        "b0145": {
            "authors": [
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Tontini"
                },
                {
                    "first": "F.",
                    "initial": "F.",
                    "last": "Berti"
                },
                {
                    "first": "M. R.",
                    "initial": "M.R.",
                    "last": "Romano"
                },
                {
                    "first": "D.",
                    "initial": "D.",
                    "last": "Proietti"
                },
                {
                    "first": "C.",
                    "initial": "C.",
                    "last": "Zambonelli"
                },
                {
                    "first": "M. J.",
                    "initial": "M.J.",
                    "last": "Bottomley"
                },
                {
                    "first": "E.",
                    "initial": "E.",
                    "last": "De Gregorio"
                },
                {
                    "first": "G.",
                    "initial": "G.",
                    "last": "Del Giudice"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Rappuoli"
                },
                {
                    "first": "P.",
                    "initial": "P.",
                    "last": "Costantino"
                }
            ],
            "doi": "10.1016/j.vaccine.2013.07.078",
            "firstpage": "4827",
            "issn": "0264410X",
            "lastpage": "4833",
            "pmid": "23965218",
            "pub_year": 2013,
            "title": "Comparison of CRM197, diphtheria toxoid and tetanus toxoid as protein carriers for meningococcal glycoconjugate vaccines",
            "volume": "31"
        },
        "b0150": {
            "authors": [
                {
                    "first": "Bernie Endyarni",
                    "initial": "B.E.",
                    "last": "Medise"
                },
                {
                    "first": "Soedjatmiko",
                    "initial": "S.",
                    "last": "Soedjatmiko"
                },
                {
                    "first": "Iris",
                    "initial": "I.",
                    "last": "Rengganis"
                },
                {
                    "first": "Hartono",
                    "initial": "H.",
                    "last": "Gunardi"
                },
                {
                    "first": "Rini",
                    "initial": "R.",
                    "last": "Sekartini"
                },
                {
                    "first": "Sukamto",
                    "initial": "S.",
                    "last": "Koesno"
                },
                {
                    "first": "Hindra Irawan",
                    "initial": "H.I.",
                    "last": "Satari"
                },
                {
                    "first": "Sri Rezeki",
                    "initial": "S.R.",
                    "last": "Hadinegoro"
                },
                {
                    "first": "Jae Seung",
                    "initial": "J.S.",
                    "last": "Yang"
                },
                {
                    "first": "Jean Louis",
                    "initial": "J.L.",
                    "last": "Excler"
                },
                {
                    "first": "Sushant",
                    "initial": "S.",
                    "last": "Sahastrabuddhe"
                },
                {
                    "first": "Mita",
                    "initial": "M.",
                    "last": "Puspita"
                },
                {
                    "first": "Rini Mulia",
                    "initial": "R.M.",
                    "last": "Sari"
                },
                {
                    "first": "Novilia Sjafri",
                    "initial": "N.S.",
                    "last": "Bachtiar"
                }
            ],
            "doi": "10.1371/journal.pone.0211784",
            "issn": "19326203",
            "pmid": "30759132",
            "pub_year": 2019,
            "title": "Six-month follow up of a randomized clinical trial-phase I study in Indonesian adults and children: Safety and immunogenicity of Salmonella typhi polysaccharide-diphtheria toxoid (VI-DT) conjugate vaccine",
            "volume": "14"
        },
        "b0155": {
            "authors": [
                {
                    "first": "Monjori",
                    "initial": "M.",
                    "last": "Mitra"
                },
                {
                    "first": "Nitin",
                    "initial": "N.",
                    "last": "Shah"
                },
                {
                    "first": "Apurba",
                    "initial": "A.",
                    "last": "Ghosh"
                },
                {
                    "first": "Suparna",
                    "initial": "S.",
                    "last": "Chatterjee"
                },
                {
                    "first": "Iqbal",
                    "initial": "I.",
                    "last": "Kaur"
                },
                {
                    "first": "Nisha",
                    "initial": "N.",
                    "last": "Bhattacharya"
                },
                {
                    "first": "Suparna",
                    "initial": "S.",
                    "last": "Basu"
                }
            ],
            "doi": "10.1080/21645515.2015.1117715",
            "firstpage": "939",
            "issn": "21645515",
            "lastpage": "945",
            "pmid": "26901576",
            "pub_year": 2016,
            "title": "Efficacy and safety of vi-tetanus toxoid conjugated typhoid vaccine (PedaTyph\u2122) in Indian children: School based cluster randomized study",
            "volume": "12"
        },
        "b0160": {
            "authors": [
                {
                    "first": "Do Gia",
                    "initial": "D.G.",
                    "last": "Canh"
                },
                {
                    "first": "Feng Ying",
                    "initial": "F.Y.",
                    "last": "Lin"
                },
                {
                    "first": "Vu Dinh",
                    "initial": "V.D.",
                    "last": "Thiem"
                },
                {
                    "first": "Dang Due",
                    "initial": "D.D.",
                    "last": "Trach"
                },
                {
                    "first": "Nguyen Dinh",
                    "initial": "N.D.",
                    "last": "Trong"
                },
                {
                    "first": "Nguyen Due",
                    "initial": "N.D.",
                    "last": "Mao"
                },
                {
                    "first": "Steven",
                    "initial": "S.",
                    "last": "Hunt"
                },
                {
                    "first": "Rachel",
                    "initial": "R.",
                    "last": "Schneerson"
                },
                {
                    "first": "John B.",
                    "initial": "J.B.",
                    "last": "Robbins"
                },
                {
                    "first": "Chiayung",
                    "initial": "C.",
                    "last": "Chu"
                },
                {
                    "first": "Joseph",
                    "initial": "J.",
                    "last": "Shiloach"
                },
                {
                    "first": "Dolores A.",
                    "initial": "D.A.",
                    "last": "Bryla"
                },
                {
                    "first": "Marie Claude",
                    "initial": "M.C.",
                    "last": "Bonnet"
                },
                {
                    "first": "Dominique",
                    "initial": "D.",
                    "last": "Schulz"
                },
                {
                    "first": "Shousun C.",
                    "initial": "S.C.",
                    "last": "Szu"
                }
            ],
            "doi": "10.1128/IAI.72.11.6586-6588.2004",
            "firstpage": "6586",
            "issn": "00199567",
            "lastpage": "6588",
            "pmid": "15501790",
            "pub_year": 2004,
            "title": "Effect of dosage on immunogenicity of a Vi conjugate vaccine injected twice into 2- to 5-year-old Vietnamese children",
            "volume": "72"
        },
        "b0165": {
            "authors": [
                {
                    "first": "Vadrevu Krishna",
                    "initial": "V.K.",
                    "last": "Mohan"
                },
                {
                    "first": "Vineeth",
                    "initial": "V.",
                    "last": "Varanasi"
                },
                {
                    "first": "Anit",
                    "initial": "A.",
                    "last": "Singh"
                },
                {
                    "first": "Marcela F.",
                    "initial": "M.F.",
                    "last": "Pasetti"
                },
                {
                    "first": "Myron M.",
                    "initial": "M.M.",
                    "last": "Levine"
                },
                {
                    "first": "Ramasamy",
                    "initial": "R.",
                    "last": "Venkatesan"
                },
                {
                    "first": "Krishna M.",
                    "initial": "K.M.",
                    "last": "Ella"
                }
            ],
            "doi": "10.1093/cid/civ295",
            "firstpage": "393",
            "issn": "10584838",
            "lastpage": "402",
            "pmid": "25870324",
            "pub_year": 2015,
            "title": "Safety and Immunogenicity of a Vi Polysaccharide-Tetanus Toxoid Conjugate Vaccine (Typbar-TCV) in Healthy Infants, Children, and Adults in Typhoid Endemic Areas: A Multicenter, 2-Cohort, Open-Label, Double-Blind, Randomized Controlled Phase 3 Study",
            "volume": "61"
        },
        "b0170": null
    },
    "body_text": [
        {
            "endOffset": 19124,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Blood samples were collected prior to vaccination and 4 weeks post investigational product (IP) administration for immunogenicity assessment.",
            "startOffset": 18983,
            "title": "Study design and participants"
        },
        {
            "endOffset": 16065,
            "parents": [],
            "secId": "s0005",
            "sentence": "The World Health Organization (WHO) cited the increasing problem of antibiotic-resistant S. Typhi as one of the key rationales for typhoid fever vaccination in populations at high risk of infection.",
            "startOffset": 15867,
            "title": "Introduction"
        },
        {
            "endOffset": 21381,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Rash and nasopharyngitis were described in protocol as possible MMR vaccine-specific adverse events and were collected for 7 days following the vaccine administration for the toddlers aged 9 to less than 12 months.",
            "startOffset": 21167,
            "title": "Assessment of safety and reactogenicity"
        },
        {
            "endOffset": 28224,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "All unsolicited AEs reported were of mild to moderate severity, and most of them were assessed unrelated to Vi-DT or placebo administration.",
            "startOffset": 28084,
            "title": "Safety evaluation"
        },
        {
            "endOffset": 27802,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "All solicited AEs reported were mild to moderate in severity, except one case of severe fever in a Vi-DT recipient in the 6 to <9 month age stratum that resolved without sequelae.",
            "startOffset": 27623,
            "title": "Safety evaluation"
        },
        {
            "endOffset": 29821,
            "parents": [],
            "refoffsets": {
                "b0130": {
                    "endOffset": 29820,
                    "startOffset": 29813
                },
                "b0135": {
                    "endOffset": 29820,
                    "startOffset": 29813
                },
                "b0140": {
                    "endOffset": 29820,
                    "startOffset": 29813
                }
            },
            "secId": "s0065",
            "sentence": "Carrier proteins such as recombinant exoprotein A from Pseudomonas aeruginosa (rEPA), tetanus toxoid (TT), diphtheria toxoid (DT) or a non-toxic mutant of diphtheria toxin (CRM 197) have been used successfully for Vi conjugate vaccines [26\u201328].",
            "startOffset": 29577,
            "title": "Discussion"
        },
        {
            "endOffset": 18712,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Eligible participants enrolled into the study were randomized into one of three groups (Groups A, B, and C).",
            "startOffset": 18604,
            "title": "Study design and participants"
        },
        {
            "endOffset": 19775,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "The immunogenicity and safety data through 4 weeks of study were cleaned, locked, and un-blinded for analysis.",
            "startOffset": 19665,
            "title": "Study design and participants"
        },
        {
            "endOffset": 22295,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0115": {
                    "endOffset": 22294,
                    "startOffset": 22287
                },
                "b0125": {
                    "endOffset": 22294,
                    "startOffset": 22287
                }
            },
            "secId": "s0030",
            "sentence": "An anti-Vi IgG ELISA was used to measure anti-Vi specific antibodies of the IgG isotype in human sera as previously described [23,25].",
            "startOffset": 22161,
            "title": "Assessment of immunogenicity"
        },
        {
            "endOffset": 20533,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "IP (Test vaccine/Placebo) were stored at +2\u20138 \u00b0C at the RITM facility.",
            "startOffset": 20463,
            "title": "Investigational product"
        },
        {
            "endOffset": 17531,
            "parents": [],
            "refoffsets": {
                "b0115": {
                    "endOffset": 17530,
                    "startOffset": 17526
                }
            },
            "secId": "s0005",
            "sentence": "Vi-DT was safe, well tolerated, and immunogenic in a Phase I clinical trial carried out in 144 healthy Filipino subjects aged 2\u201345 years [23].",
            "startOffset": 17389,
            "title": "Introduction"
        },
        {
            "endOffset": 25954,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                },
                {
                    "id": "s0050",
                    "title": "Immunogenicity evaluation"
                }
            ],
            "secId": "s0055",
            "sentence": "GMT rose from baseline to 28 days post-test dose by 1272.59 fold (95% CI: 1077.26, 1503.32) in Vi-DT recipients while GMT among placebo recipients showed negligible change (0.97 fold, 95% CI: 0.69, 1.35) (p < 0.0001).",
            "startOffset": 25737,
            "title": "Immunogenicity set analysis"
        },
        {
            "endOffset": 19403,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "The study evaluates primary immunogenicity endpoint which is the rate of anti-Vi seroconversion in age-stratified recipients after a single dose of Vi-DT or placebo.",
            "startOffset": 19238,
            "title": "Study design and participants"
        },
        {
            "endOffset": 17388,
            "parents": [],
            "secId": "s0005",
            "sentence": "The International Vaccine Institute (IVI) in collaboration with SK bioscience developed a typhoid conjugate vaccine consisting of Vi polysaccharide [India clinical isolate (C6524)] conjugated to diphtheria toxoid.",
            "startOffset": 17175,
            "title": "Introduction"
        },
        {
            "endOffset": 23233,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0035",
            "sentence": "An analysis of covariance model was performed as a sensitivity analysis in examining the differences of GMT and GM fold rise that are related to the effect of controlled baseline characteristics.",
            "startOffset": 23038,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 14746,
            "parents": [],
            "secId": "s0005",
            "sentence": "All age groups are prone to typhoid infection but school-aged children (5\u201315 years old) are most significantly impacted.",
            "startOffset": 14626,
            "title": "Introduction"
        },
        {
            "endOffset": 30790,
            "parents": [],
            "refoffsets": {
                "b0140": {
                    "endOffset": 30789,
                    "startOffset": 30776
                },
                "b0150": {
                    "endOffset": 30789,
                    "startOffset": 30776
                },
                "b0155": {
                    "endOffset": 30789,
                    "startOffset": 30776
                },
                "b0160": {
                    "endOffset": 30789,
                    "startOffset": 30776
                },
                "b0165": {
                    "endOffset": 30789,
                    "startOffset": 30776
                },
                "b0170": {
                    "endOffset": 30789,
                    "startOffset": 30776
                }
            },
            "secId": "s0065",
            "sentence": "Overall, Phase II Vi-DT single dose results confirmed the findings in the Phase I study in the Philippines and in Indonesia, with a safety profile in line with that of other Vi- polysaccharide conjugate vaccines [28,30,31\u201334].",
            "startOffset": 30564,
            "title": "Discussion"
        },
        {
            "endOffset": 23037,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0035",
            "sentence": "This endpoint was tested at the interim analysis with type 1 error rate of 0.0125 (one-sided test from stratified CMH test) to control overall study wise type 1 error rate of 0.025.",
            "startOffset": 22856,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 20200,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "The Vi-DT vaccine contains two active ingredients, 25 \u00b5g of purified Vi polysaccharide (S. Typhi C6524) conjugated with diphtheria toxoid (Corynebacterium diphtheria PW No.8) and formulated with stabilizers.",
            "startOffset": 19993,
            "title": "Investigational product"
        },
        {
            "endOffset": 17174,
            "parents": [],
            "refoffsets": {
                "b0120": {
                    "endOffset": 17173,
                    "startOffset": 17169
                }
            },
            "secId": "s0005",
            "sentence": "Typbar-TCV\u00ae (Bharat Biotech International Ltd) was prequalified by WHO in January 2018 [24].",
            "startOffset": 17082,
            "title": "Introduction"
        },
        {
            "endOffset": 29340,
            "parents": [],
            "secId": "s0065",
            "sentence": "For the polysaccharide vaccines, these limitations can be overcome by conjugation of the Vi polysaccharide to a carrier protein.",
            "startOffset": 29212,
            "title": "Discussion"
        },
        {
            "endOffset": 31053,
            "parents": [],
            "secId": "s0065",
            "sentence": "Similar results were seen within each age stratum.",
            "startOffset": 31003,
            "title": "Discussion"
        },
        {
            "endOffset": 25736,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                },
                {
                    "id": "s0050",
                    "title": "Immunogenicity evaluation"
                }
            ],
            "secId": "s0055",
            "sentence": "Four weeks (28 days) post single dose, anti-Vi IgG ELISA GMT were 444.38 IU/ml (95% CI: 400.28, 493.34) and 0.41 IU/ml (95% CI: 0.33, 0.51) in Vi-DT and placebo groups, respectively (P < 0.0001) among all study participants combined.",
            "startOffset": 25503,
            "title": "Immunogenicity set analysis"
        },
        {
            "endOffset": 19238,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "At 24 weeks, Groups A and C will receive a non-typhoid vaccine while Group B will receive a second dose of Vi-DT.",
            "startOffset": 19125,
            "title": "Study design and participants"
        },
        {
            "endOffset": 32472,
            "parents": [],
            "secId": "s0065",
            "sentence": "These data support the potent immunogenicity and satisfactory safety profile of Vi-DT in 6\u201323 month-old participants and set the stage for further clinical development of Vi-DT in larger number of participants and broader target populations of 6 months to 45 years of age.",
            "startOffset": 32200,
            "title": "Discussion"
        },
        {
            "endOffset": 22024,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Blinded safety data were regularly reviewed by the sponsor\u2019s Safety Monitoring Committee (SMC).",
            "startOffset": 21929,
            "title": "Assessment of safety and reactogenicity"
        },
        {
            "endOffset": 29211,
            "parents": [],
            "secId": "s0065",
            "sentence": "Vi polysaccharide vaccine cannot be used below 2 years due to lack of T-cell dependent response.",
            "startOffset": 29115,
            "title": "Discussion"
        },
        {
            "endOffset": 23405,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0035",
            "sentence": "The immunogenicity set was defined as participants who were randomized, received at least one dose of IP and provided at least one post baseline measure for immunogenicity.",
            "startOffset": 23233,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 26809,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "A Vi-DT participant from the 9\u201312 months of age strata experienced an immediate reaction (erythema/redness and fever) after vaccination; mild in severity and resolved without sequelae.",
            "startOffset": 26625,
            "title": "Safety evaluation"
        },
        {
            "endOffset": 28044,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "At 4 weeks, unsolicited AEs were reported by 60.09% (95% CI: 53.61, 66.23) and 66.67% (95% CI: 53.72, 77.51) of participants in the Vi-DT and placebo groups, respectively and was not statistically significant at 0.05 type 1 error (two sided).",
            "startOffset": 27802,
            "title": "Safety evaluation"
        },
        {
            "endOffset": 30262,
            "parents": [],
            "refoffsets": {
                "b0115": {
                    "endOffset": 30261,
                    "startOffset": 30254
                },
                "b0150": {
                    "endOffset": 30261,
                    "startOffset": 30254
                }
            },
            "secId": "s0065",
            "sentence": "Typhoid Vi polysaccharide conjugated to DT as carrier protein was therefore a logical choice for development and Vi-DT had thus been evaluated in phase I clinical trials in the Philippines and Indonesia with potent immune responses in children and adults and no apparent safety concerns [23,30].",
            "startOffset": 29967,
            "title": "Discussion"
        },
        {
            "endOffset": 14107,
            "parents": [],
            "secId": "s0005",
            "sentence": "Typhoid fever, an invasive bacterial infection caused by Salmonella enterica serovar Typhi (S. Typhi), remains an important public health problem, especially in low- and middle-income countries.",
            "startOffset": 13913,
            "title": "Introduction"
        },
        {
            "endOffset": 20462,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Vi-DT and Placebo were given intramuscularly into the anterolateral left thigh of the infants and toddlers.",
            "startOffset": 20355,
            "title": "Investigational product"
        },
        {
            "endOffset": 14260,
            "parents": [],
            "refoffsets": {
                "b0005": {
                    "endOffset": 14259,
                    "startOffset": 14256
                }
            },
            "secId": "s0005",
            "sentence": "It is a common cause of bacteremia in many resource-poor settings, with most of the cases being reported from the Indian subcontinent of South Asia [1].",
            "startOffset": 14108,
            "title": "Introduction"
        },
        {
            "endOffset": 31554,
            "parents": [],
            "refoffsets": {
                "b0165": {
                    "endOffset": 31553,
                    "startOffset": 31549
                }
            },
            "secId": "s0065",
            "sentence": "Vi-TT conjugate vaccine prequalified by WHO was administered as a single dose in infants and toddlers aged 6\u201323 months and the seroconversion rate (>4-fold rise at day 42 over day 0 baseline) was reported as 98.1% (95% CI: 95.7, 99.2), 97.8% (95% CI: 93.6, 99.5) and 98.2% (95% CI: 94.6, 99.6) in the following age groups respectively, 6\u201323 months, 6\u201311 months and 12\u201323 months [33].",
            "startOffset": 31171,
            "title": "Discussion"
        },
        {
            "endOffset": 24945,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0045",
            "sentence": "Of those randomized, 228 (100%) in Test and 57 (100%) in Placebo group completed the first dose administration and the 4-week follow-up (Fig. 1) and were included in this analysis.",
            "startOffset": 24765,
            "title": "Study population"
        },
        {
            "endOffset": 15867,
            "parents": [],
            "refoffsets": {
                "b0070": {
                    "endOffset": 15866,
                    "startOffset": 15859
                },
                "b0075": {
                    "endOffset": 15866,
                    "startOffset": 15859
                },
                "b0080": {
                    "endOffset": 15866,
                    "startOffset": 15859
                },
                "b0085": {
                    "endOffset": 15866,
                    "startOffset": 15859
                },
                "b0090": {
                    "endOffset": 15866,
                    "startOffset": 15859
                },
                "b0095": {
                    "endOffset": 15866,
                    "startOffset": 15859
                },
                "b0100": {
                    "endOffset": 15866,
                    "startOffset": 15859
                }
            },
            "secId": "s0005",
            "sentence": "Resistance to the traditional first-line antibiotics ampicillin, chloramphenicol, and trimethoprim sulfamethoxazole developed in the late 1980s, then fluoroquinolone resistance in the 1990s, and more recently extended to cephalosporins have emerged in Asia and Africa [14\u201320].",
            "startOffset": 15591,
            "title": "Introduction"
        },
        {
            "endOffset": 30563,
            "parents": [],
            "secId": "s0065",
            "sentence": "All solicited and unsolicited AEs were mild or moderate in intensity in both the groups and the one SAE was not related to vaccination.",
            "startOffset": 30428,
            "title": "Discussion"
        },
        {
            "endOffset": 16315,
            "parents": [],
            "refoffsets": {
                "b0025": {
                    "endOffset": 16235,
                    "startOffset": 16229
                },
                "b0105": {
                    "endOffset": 16235,
                    "startOffset": 16229
                },
                "b0110": {
                    "endOffset": 16314,
                    "startOffset": 16310
                }
            },
            "secId": "s0005",
            "sentence": "The prevention of typhoid fever through immunization and other measures has the potential to decrease antibiotic use and limit the emergence of resistant S. Typhi [5,21], providing a short-to-medium term measure to lower typhoid disease burden [22].",
            "startOffset": 16066,
            "title": "Introduction"
        },
        {
            "endOffset": 22453,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0030",
            "sentence": "The level of the specific anti-Vi IgG as international unit (IU) units for each serum sample was determined by comparison to a reference serum (NIBSC 16/138).",
            "startOffset": 22295,
            "title": "Assessment of immunogenicity"
        },
        {
            "endOffset": 14626,
            "parents": [],
            "refoffsets": {
                "b0020": {
                    "endOffset": 14625,
                    "startOffset": 14622
                }
            },
            "secId": "s0005",
            "sentence": "According to the Department of Health, a total 22,234 suspected typhoid cases were reported nationwide from Jan 1 to Dec 3, 2018 [4].",
            "startOffset": 14493,
            "title": "Introduction"
        },
        {
            "endOffset": 18827,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "The study was further age-stratified within each group: 6 to less than 9 months, 9\u201312 months, and 13 to 23 months.",
            "startOffset": 18713,
            "title": "Study design and participants"
        },
        {
            "endOffset": 17081,
            "parents": [],
            "secId": "s0005",
            "sentence": "Three Vi polysaccharide vaccines conjugated to tetanus toxoid as carrier protein are licensed in India for use from 6 months of age.",
            "startOffset": 16949,
            "title": "Introduction"
        },
        {
            "endOffset": 28504,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "Gastroenteritis was reported by 31 (13.60%) and 16 (28.07%) among the Vi-DT and placebo recipients, respectively.",
            "startOffset": 28391,
            "title": "Safety evaluation"
        },
        {
            "endOffset": 18982,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "MMR was co-administered to those 9\u201312 months of age.",
            "startOffset": 18930,
            "title": "Study design and participants"
        },
        {
            "endOffset": 28874,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "No SAEs were reported from the placebo group.",
            "startOffset": 28829,
            "title": "Safety evaluation"
        },
        {
            "endOffset": 27107,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "There was no statistical difference in the proportions of participants who experienced solicited AEs within 7 days between Vi-DT and placebo groups: 25.88% (95% CI: 20.63, 31.93) and 19.30% (95% CI: 11.13, 31.34), respectively and was not statistically significant at 0.05 type 1 error (two sided).",
            "startOffset": 26809,
            "title": "Safety evaluation"
        },
        {
            "endOffset": 15590,
            "parents": [],
            "secId": "s0005",
            "sentence": "Although typhoid fever can be treated with antibiotics, the emergence of multidrug resistant (MDR) and extremely drug resistant (XDR) strains of S. Typhi has important and unfortunate implications.",
            "startOffset": 15393,
            "title": "Introduction"
        },
        {
            "endOffset": 28083,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "Table 5 provides a summary of all AEs.",
            "startOffset": 28045,
            "title": "Safety evaluation"
        },
        {
            "endOffset": 28390,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "During the 28 days post administration, in all age strata, 59 (25.88%) among the Vi-DT and 13 (22.81%) among the placebo recipients had acute respiratory infections.",
            "startOffset": 28225,
            "title": "Safety evaluation"
        },
        {
            "endOffset": 32200,
            "parents": [],
            "secId": "s0065",
            "sentence": "Though, immune results from the above mentioned studies can\u2019t be compared & concluded directly because of the different ELISA assay methods used for anti-Vi IgG testing.",
            "startOffset": 32031,
            "title": "Discussion"
        },
        {
            "endOffset": 16949,
            "parents": [],
            "refoffsets": {
                "b0105": {
                    "endOffset": 16948,
                    "startOffset": 16944
                }
            },
            "secId": "s0005",
            "sentence": "WHO recommends that the introduction of TCV should be prioritized in countries having high burden of typhoid disease [21].",
            "startOffset": 16827,
            "title": "Introduction"
        },
        {
            "endOffset": 26416,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                },
                {
                    "id": "s0050",
                    "title": "Immunogenicity evaluation"
                }
            ],
            "secId": "s0055",
            "sentence": "Looking at age-stratified data, the GMT fold-increase from baseline to 28 days post-test dose was 1006.84 (95% CI: 753.02, 1346.21), 1730.45 (95% CI: 1320.94, 2266.91), and 1182.89 (95% CI: 872.07, 1604.49) in 6 to <9 months, 9 to 12 months, and 13 to 23 months, respectively while the GMT fold-increase in the corresponding placebo groups were 0.74 (95% CI: 0.41, 1.32), 1.10 (95% CI: 0.64, 1.89) and 1.12 (95% CI: 0.61, 2.06), respectively (Fig. 3) (Table 3).",
            "startOffset": 25955,
            "title": "Immunogenicity set analysis"
        },
        {
            "endOffset": 18340,
            "parents": [],
            "secId": "s0010",
            "sentence": "Before study participation, written informed consent was obtained from the parents or legal guardians of trial participants.",
            "startOffset": 18216,
            "title": "Materials and methods"
        },
        {
            "endOffset": 17949,
            "parents": [],
            "secId": "s0010",
            "sentence": "This phase II clinical trial (Clinicaltrials.gov NCT03527355) was approved by the Philippines Food and Drug Administration (PFDA) and the Institutional Review Boards (IRB) of the Research Institute for Tropical Medicine (RITM) and IVI.",
            "startOffset": 17714,
            "title": "Materials and methods"
        },
        {
            "endOffset": 27622,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "Due to the co-administration of MMR, nasopharyngitis was the most commonly reported systemic AE in the 9\u201312 months age strata and the proportion of participants reported was similar between the Vi-DT (23.68%) and placebo (21.05%) groups.",
            "startOffset": 27385,
            "title": "Safety evaluation"
        },
        {
            "endOffset": 20669,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Immediate reactions were assessed at the clinical trial site for 60 min following vaccination.",
            "startOffset": 20575,
            "title": "Assessment of safety and reactogenicity"
        },
        {
            "endOffset": 32030,
            "parents": [],
            "refoffsets": {
                "b0165": {
                    "endOffset": 31857,
                    "startOffset": 31853
                }
            },
            "secId": "s0065",
            "sentence": "At 42 days post single dose of Vi-TT, anti-Vi IgG GMT fold increases over baseline were 205, 193, and 215 in age strata of 6-23 months, 6\u201311 months, and 12\u201323 months, respectively [33] while at day 28 post Vi-DT GMT fold increases of 1272.59, 1006.84, 11730.45, and 1182.89 in age strata 6-23 months, 6\u2013<9 months, 9\u201312 months and 13\u201323 months, respectively.",
            "startOffset": 31673,
            "title": "Discussion"
        },
        {
            "endOffset": 27228,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "Table 4 provides the proportion of participants with solicited AEs by group, by ages combined and individual age strata.",
            "startOffset": 27108,
            "title": "Safety evaluation"
        },
        {
            "endOffset": 28748,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "One unrelated SAE with the diagnosis of febrile convulsion secondary to urinary tract infection was reported 5 days after Vi-DT administration in the 6 to <9-month age stratum.",
            "startOffset": 28572,
            "title": "Safety evaluation"
        },
        {
            "endOffset": 18215,
            "parents": [],
            "secId": "s0010",
            "sentence": "The study was conducted in compliance with International Council for Harmonization (ICH) Good Clinical Practice (GCP) E6 (R2) and E11, Belmont Principles, CIOMS guidelines, Declaration of Helsinki and other applicable regulations in the Republic of the Philippines.",
            "startOffset": 17950,
            "title": "Materials and methods"
        },
        {
            "endOffset": 19524,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "For the purpose of this report we will refer to Groups A and B combined as the Vi-DT group and Group C as placebo group.",
            "startOffset": 19404,
            "title": "Study design and participants"
        },
        {
            "endOffset": 28828,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "It was mild in severity and resolved without sequelae after medical management.",
            "startOffset": 28749,
            "title": "Safety evaluation"
        },
        {
            "endOffset": 22756,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0035",
            "sentence": "Seroconversion rate was defined as the proportion of participants with at least 4-fold rise anti-Vi IgG ELISA antibody titers (with 95% CI for each group) at week 4 as compared to baseline (Day 0).",
            "startOffset": 22559,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 21587,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Unsolicited Adverse Events were defined as, any adverse event not specifically documented among the solicited AE that occurred from the date of administration of the test vaccine or placebo from days 0\u201328.",
            "startOffset": 21382,
            "title": "Assessment of safety and reactogenicity"
        },
        {
            "endOffset": 14882,
            "parents": [],
            "refoffsets": {
                "b0025": {
                    "endOffset": 14881,
                    "startOffset": 14875
                },
                "b0030": {
                    "endOffset": 14881,
                    "startOffset": 14875
                },
                "b0035": {
                    "endOffset": 14881,
                    "startOffset": 14875
                },
                "b0040": {
                    "endOffset": 14881,
                    "startOffset": 14875
                },
                "b0045": {
                    "endOffset": 14881,
                    "startOffset": 14875
                },
                "b0050": {
                    "endOffset": 14881,
                    "startOffset": 14875
                },
                "b0055": {
                    "endOffset": 14881,
                    "startOffset": 14875
                },
                "b0060": {
                    "endOffset": 14881,
                    "startOffset": 14875
                },
                "b0065": {
                    "endOffset": 14881,
                    "startOffset": 14875
                }
            },
            "secId": "s0005",
            "sentence": "In some endemic areas, children under 5 years of age have incidence rates similar to or exceeding those of school-aged children [5\u201313].",
            "startOffset": 14747,
            "title": "Introduction"
        },
        {
            "endOffset": 25503,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                },
                {
                    "id": "s0050",
                    "title": "Immunogenicity evaluation"
                }
            ],
            "secId": "s0055",
            "sentence": "The seroconversion rate was 100% (95% CI: 95.19, 100.0) in all 3 age strata while rates in placebo recipients were 10.53% (95% CI: 2.94, 31.39), 5.26% (95% CI: 0.94, 24.64), and 5.26% (95% CI: 0.94, 24.64), respectively (Fig. 2, Table 2).",
            "startOffset": 25265,
            "title": "Immunogenicity set analysis"
        },
        {
            "endOffset": 16453,
            "parents": [],
            "refoffsets": {
                "b0105": {
                    "endOffset": 16452,
                    "startOffset": 16448
                }
            },
            "secId": "s0005",
            "sentence": "Typhoid vaccines licensed and recommended for use are live attenuated Ty21a, Vi polysaccharide, and typhoid conjugate vaccines (TCV) [21].",
            "startOffset": 16315,
            "title": "Introduction"
        },
        {
            "endOffset": 23841,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0035",
            "sentence": "Safety was assessed for all randomized participants who received at least one vaccination.",
            "startOffset": 23751,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 20354,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Placebo was 0.5 mL of 0.9% sodium chloride isotonic solution (EuroMed Inc, Manila, Philippines).",
            "startOffset": 20258,
            "title": "Investigational product"
        },
        {
            "endOffset": 28572,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "There were no specific safety signals reported from any age strata.",
            "startOffset": 28505,
            "title": "Safety evaluation"
        },
        {
            "endOffset": 27384,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "Irrespective of group and age strata, pain and tenderness were the most common local solicited AEs; while fever was the most commonly reported systemic AE.",
            "startOffset": 27229,
            "title": "Safety evaluation"
        },
        {
            "endOffset": 18929,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Groups A and B received a single dose of Vi-DT (25 \u03bcg) and Group C received a single dose of placebo.",
            "startOffset": 18828,
            "title": "Study design and participants"
        },
        {
            "endOffset": 24764,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0045",
            "sentence": "The most frequently reported cause of screen failure was related to health condition of potential participants (i.e., acute illness, abnormal clinical exam, lab values abnormalities).",
            "startOffset": 24581,
            "title": "Study population"
        },
        {
            "endOffset": 14997,
            "parents": [],
            "refoffsets": {
                "b0045": {
                    "endOffset": 14996,
                    "startOffset": 14993
                }
            },
            "secId": "s0005",
            "sentence": "A systematic review reported that a median of 58% of typhoid fever episodes occurred in children <5 years old [9].",
            "startOffset": 14883,
            "title": "Introduction"
        },
        {
            "endOffset": 21706,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Unsolicited AEs were classified into System Organ Class (SOC) and Preferred Term (PT) using MedDRA (version 21, 2018).",
            "startOffset": 21588,
            "title": "Assessment of safety and reactogenicity"
        },
        {
            "endOffset": 21016,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Solicited local adverse reactions included pain, tenderness, erythema/redness, swelling/induration and pruritus at the injection site.",
            "startOffset": 20882,
            "title": "Assessment of safety and reactogenicity"
        },
        {
            "endOffset": 31672,
            "parents": [],
            "secId": "s0065",
            "sentence": "Similar seroconversion rates after single dose Vi-DT were seen: 100% (95% CI: 98.34, 100.0) in all ages in our study.",
            "startOffset": 31555,
            "title": "Discussion"
        },
        {
            "endOffset": 23751,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0035",
            "sentence": "Demographic characteristics of continuous variables were summarized by number of participants, mean, standard deviation, median, minimum and maximum, and categorical variables were summarized by frequency and percentage in each vaccine group.",
            "startOffset": 23509,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 19664,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "This pre-specified interim analysis was performed after all participants completed the week 4 visit in order to facilitate Phase 3 planning.",
            "startOffset": 19524,
            "title": "Study design and participants"
        },
        {
            "endOffset": 29577,
            "parents": [],
            "refoffsets": {
                "b0130": {
                    "endOffset": 29576,
                    "startOffset": 29572
                }
            },
            "secId": "s0065",
            "sentence": "Conjugation of a bacterial polysaccharide to a carrier protein converts the immune response from T-cell independent to T-cell dependent characterized by antibody affinity maturation, IgG subclass switching, and induction of memory [26].",
            "startOffset": 29341,
            "title": "Discussion"
        },
        {
            "endOffset": 21928,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Serious adverse events (SAE) were recorded during the entire study period.",
            "startOffset": 21854,
            "title": "Assessment of safety and reactogenicity"
        },
        {
            "endOffset": 25264,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                },
                {
                    "id": "s0050",
                    "title": "Immunogenicity evaluation"
                }
            ],
            "secId": "s0055",
            "sentence": "All participants in Vi-DT group showed 100% (95% CI: 98.34, 100.0) seroconversion post single dose vs 7.02% (95% CI: 2.76, 16.70) in the placebo group (P < 0.0001).",
            "startOffset": 25100,
            "title": "Immunogenicity set analysis"
        },
        {
            "endOffset": 15393,
            "parents": [],
            "refoffsets": {
                "b0025": {
                    "endOffset": 15392,
                    "startOffset": 15389
                }
            },
            "secId": "s0005",
            "sentence": "Typhoid fever surveillance or epidemiology studies carried out between 1998 and 2017 in Africa, Asia, and the Americas with >10,000 blood culture-confirmed cases of typhoid fever sufficiently severe to require outpatient or inpatient care showed that 27% of all cases occurred in children aged 0\u20134 years; 30% of those cases occurred in children aged <2 years and 10% in infants aged <1 year [5].",
            "startOffset": 14998,
            "title": "Introduction"
        },
        {
            "endOffset": 29966,
            "parents": [],
            "refoffsets": {
                "b0145": {
                    "endOffset": 29965,
                    "startOffset": 29961
                }
            },
            "secId": "s0065",
            "sentence": "DT is known for its safety profile and is considered as a reliable carrier protein, successfully used for meningococcal conjugate vaccines [29].",
            "startOffset": 29822,
            "title": "Discussion"
        },
        {
            "endOffset": 14492,
            "parents": [],
            "refoffsets": {
                "b0015": {
                    "endOffset": 14491,
                    "startOffset": 14488
                }
            },
            "secId": "s0005",
            "sentence": "Although the information of typhoid fever burden is scattered, typhoid is endemic in the Philippines [3].",
            "startOffset": 14387,
            "title": "Introduction"
        },
        {
            "endOffset": 21166,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Solicited systemic adverse reactions included fever, lethargy, irritability, vomiting, diarrhea, drowsiness, loss of appetite, and persistent crying.",
            "startOffset": 21017,
            "title": "Assessment of safety and reactogenicity"
        },
        {
            "endOffset": 21853,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Participants were invited to visit the study site on Days 3, 7, and 28 after injection for safety assessment and in case of development of any AE.",
            "startOffset": 21707,
            "title": "Assessment of safety and reactogenicity"
        },
        {
            "endOffset": 20257,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "It is presented in liquid form at 0.5 mL per glass vial.",
            "startOffset": 20201,
            "title": "Investigational product"
        },
        {
            "endOffset": 29114,
            "parents": [],
            "refoffsets": {
                "b0025": {
                    "endOffset": 29113,
                    "startOffset": 29110
                }
            },
            "secId": "s0065",
            "sentence": "In 2017 the World Health Organization Strategic Advisory Group of Experts (SAGE) on immunization recommended the introduction of TCV for infants and children over 6 months of age as a single dose in typhoid-endemic countries [5].",
            "startOffset": 28885,
            "title": "Discussion"
        },
        {
            "endOffset": 23977,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0035",
            "sentence": "The proportion of participants who experienced solicited and unsolicited AEs after dose was provided with the 95% CI of the proportion.",
            "startOffset": 23842,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 24357,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0035",
            "sentence": "Assuming 10% dropout rate, the sample size of n = 228 for Vi-DT group vs. n = 57 Placebo group provided >99% power to detect the superiority of seroconversion rate in Vi-DT regimen compared to Placebo with one-sided test at 0.0125 significance level.",
            "startOffset": 24107,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 24580,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0045",
            "sentence": "Among 515 participants screened, 285 participants were enrolled and randomized to either Test vaccine or Placebo at a 4:1 ratio.",
            "startOffset": 24452,
            "title": "Study population"
        },
        {
            "endOffset": 30933,
            "parents": [],
            "secId": "s0065",
            "sentence": "All subjects in Vi-DT group (100%) seroconverted, with a greater than 4-fold rise in serum anti-Vi IgG 28 days after the initial dose of Vi-DT.",
            "startOffset": 30790,
            "title": "Discussion"
        },
        {
            "endOffset": 14386,
            "parents": [],
            "refoffsets": {
                "b0010": {
                    "endOffset": 14385,
                    "startOffset": 14382
                }
            },
            "secId": "s0005",
            "sentence": "Global estimates suggest that there are approximately 10.9 million cases and 116.8 thousand deaths annually from typhoid [2].",
            "startOffset": 14261,
            "title": "Introduction"
        },
        {
            "endOffset": 20881,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Parents/guardians were provided with a thermometer and diary cards (DC) to record axillary temperature and any adverse events (AE) daily: solicited AE for 7 days after vaccination and unsolicited AE for 28 days.",
            "startOffset": 20670,
            "title": "Assessment of safety and reactogenicity"
        },
        {
            "endOffset": 18603,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "This is a randomized, observer-blinded (safety evaluators and other trial staff remained blinded with the exception of the vaccine administrator), phase II study in healthy infants and toddlers aged 6\u201323 months at study initiation.",
            "startOffset": 18372,
            "title": "Study design and participants"
        },
        {
            "endOffset": 26547,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                },
                {
                    "id": "s0050",
                    "title": "Immunogenicity evaluation"
                }
            ],
            "secId": "s0055",
            "sentence": "Comparing age-stratified groups the differences in GMT fold-increase were statistically significant as two 95% CIs didn\u2019t overlap.",
            "startOffset": 26417,
            "title": "Immunogenicity set analysis"
        },
        {
            "endOffset": 17692,
            "parents": [],
            "secId": "s0005",
            "sentence": "This report provides information on the immunogenicity, safety, and tolerability of a single dose of Vi-DT from a Phase II trial in children 6\u201323 months of age.",
            "startOffset": 17532,
            "title": "Introduction"
        },
        {
            "endOffset": 22558,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0035",
            "sentence": "The primary immunogenicity endpoint was measured as seroconversion rate at week 4.",
            "startOffset": 22476,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 30427,
            "parents": [],
            "secId": "s0065",
            "sentence": "No subject was withdrawn from the study due to AE.",
            "startOffset": 30377,
            "title": "Discussion"
        },
        {
            "endOffset": 16640,
            "parents": [],
            "refoffsets": {
                "b0115": {
                    "endOffset": 16639,
                    "startOffset": 16635
                }
            },
            "secId": "s0005",
            "sentence": "TCV is preferred over oral and polysaccharides vaccines because of its improved immunological properties, suitability for use in younger children, and longer duration of protection [23].",
            "startOffset": 16454,
            "title": "Introduction"
        },
        {
            "endOffset": 22160,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0030",
            "sentence": "Blood serum samples from baseline and 28 days post injection were stored at \u221220 \u00b0C \u221280 \u00b0C until analysis.",
            "startOffset": 22055,
            "title": "Assessment of immunogenicity"
        },
        {
            "endOffset": 31002,
            "parents": [],
            "secId": "s0065",
            "sentence": "Only 7% of placebo recipients seroconverted in the same time period.",
            "startOffset": 30934,
            "title": "Discussion"
        },
        {
            "endOffset": 25040,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0045",
            "sentence": "Both groups were comparable with regard to demographic and baseline characteristics (Table 1).",
            "startOffset": 24946,
            "title": "Study population"
        },
        {
            "endOffset": 26624,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "There was only one immediate reaction among participants.",
            "startOffset": 26567,
            "title": "Safety evaluation"
        },
        {
            "endOffset": 24107,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0035",
            "sentence": "The incidence of solicited and unsolicited AEs by severity, causality, and outcome was presented with proportion of participants.",
            "startOffset": 23978,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 32565,
            "parents": [],
            "secId": "s0065",
            "sentence": "The current Phase II study is ongoing at RITM and the final analysis is expected in 2 years.",
            "startOffset": 32473,
            "title": "Discussion"
        },
        {
            "endOffset": 16826,
            "parents": [],
            "secId": "s0005",
            "sentence": "Vi polysaccharide and conjugate vaccines are recommended by WHO for the control of typhoid in endemic and epidemic settings along with water, sanitation and hygiene (WASH) intervention.",
            "startOffset": 16641,
            "title": "Introduction"
        },
        {
            "endOffset": 22856,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0035",
            "sentence": "The analysis of the primary endpoint was done by the stratified Cochran-Mantel-Haenszel (CMH) test.",
            "startOffset": 22757,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 23508,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0035",
            "sentence": "All randomized participants were included in the analysis of demographics and baseline characteristics.",
            "startOffset": 23405,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 24425,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0035",
            "sentence": "All analyses were performed using SAS 9.4 (SAS Institute, Cary NC).",
            "startOffset": 24358,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 19967,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "This interim analysis was performed by an independent statistician who was not directly involved in the study and study personnel remain blinded to the allocation of test vaccine and placebo.",
            "startOffset": 19776,
            "title": "Study design and participants"
        },
        {
            "endOffset": 30376,
            "parents": [],
            "secId": "s0065",
            "sentence": "In this Phase II study, Vi-DT showed to be safe, well tolerated, and immunogenic in an important target age group.",
            "startOffset": 30262,
            "title": "Discussion"
        },
        {
            "endOffset": 31171,
            "parents": [],
            "secId": "s0065",
            "sentence": "The results from this study are in agreement with other studies of typhoid conjugate vaccines in similar age cohorts.",
            "startOffset": 31054,
            "title": "Discussion"
        }
    ],
    "docId": "S0264410X19313027",
    "metadata": {
        "asjc": [
            "1313",
            "2400",
            "2725",
            "2739",
            "3400"
        ],
        "authors": [
            {
                "email": null,
                "first": "Maria Rosario",
                "initial": "M.R.",
                "last": "Capeding"
            },
            {
                "email": null,
                "first": "Edison",
                "initial": "E.",
                "last": "Alberto"
            },
            {
                "email": null,
                "first": "Arijit",
                "initial": "A.",
                "last": "Sil"
            },
            {
                "email": "tarun.saluja@ivi.int",
                "first": "Tarun",
                "initial": "T.",
                "last": "Saluja"
            },
            {
                "email": null,
                "first": "Samuel",
                "initial": "S.",
                "last": "Teshome"
            },
            {
                "email": null,
                "first": "Deok Ryun",
                "initial": "D.R.",
                "last": "Kim"
            },
            {
                "email": null,
                "first": "Ju Yeon",
                "initial": "J.Y.",
                "last": "Park"
            },
            {
                "email": null,
                "first": "Jae Seung",
                "initial": "J.S.",
                "last": "Yang"
            },
            {
                "email": null,
                "first": "Suchada",
                "initial": "S.",
                "last": "Chinaworapong"
            },
            {
                "email": null,
                "first": "Jiwook",
                "initial": "J.",
                "last": "Park"
            },
            {
                "email": null,
                "first": "Sue Kyoung",
                "initial": "S.K.",
                "last": "Jo"
            },
            {
                "email": null,
                "first": "Yun",
                "initial": "Y.",
                "last": "Chon"
            },
            {
                "email": null,
                "first": "Seon Young",
                "initial": "S.Y.",
                "last": "Yang"
            },
            {
                "email": null,
                "first": "Dong Soo",
                "initial": "D.S.",
                "last": "Ham"
            },
            {
                "email": null,
                "first": "Ji Hwa",
                "initial": "J.H.",
                "last": "Ryu"
            },
            {
                "email": null,
                "first": "Julia",
                "initial": "J.",
                "last": "Lynch"
            },
            {
                "email": null,
                "first": "Jerome H.",
                "initial": "J.H.",
                "last": "Kim"
            },
            {
                "email": null,
                "first": "Hun",
                "initial": "H.",
                "last": "Kim"
            },
            {
                "email": null,
                "first": "Jean Louis",
                "initial": "J.L.",
                "last": "Excler"
            },
            {
                "email": null,
                "first": "T. Anh",
                "initial": "T.A.",
                "last": "Wartel"
            },
            {
                "email": null,
                "first": "Sushant",
                "initial": "S.",
                "last": "Sahastrabuddhe"
            }
        ],
        "doi": "10.1016/j.vaccine.2019.09.074",
        "issn": "0264410X",
        "keywords": [
            "Immunogenicity",
            "Infants",
            "Philippines",
            "Safety",
            "Toddlers",
            "Typhoid conjugate vaccine",
            "Typhoid fever",
            "Vi-DT"
        ],
        "openaccess": "Full",
        "pub_year": 2019,
        "subjareas": [
            "BIOC",
            "IMMU",
            "MEDI",
            "VETE"
        ],
        "title": "Immunogenicity, safety and reactogenicity of a Phase II trial of Vi-DT typhoid conjugate vaccine in healthy Filipino infants and toddlers: A preliminary report"
    }
}